持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/06/12 | 1,263 | 1,277 | 1,241 | 1,244 | -19 | -1.5% | 112,000 |
| 2013/06/11 | 1,238 | 1,285 | 1,225 | 1,263 | +26 | +2.1% | 197,000 |
| 2013/06/10 | 1,186 | 1,259 | 1,186 | 1,237 | +81 | +7% | 161,000 |
| 2013/06/07 | 1,167 | 1,179 | 1,142 | 1,156 | -41 | -3.4% | 216,000 |
| 2013/06/06 | 1,195 | 1,224 | 1,186 | 1,197 | -28 | -2.3% | 174,000 |
| 2013/06/05 | 1,230 | 1,269 | 1,224 | 1,225 | -25 | -2% | 139,000 |
| 2013/06/04 | 1,219 | 1,257 | 1,216 | 1,250 | +5 | +0.4% | 168,000 |
| 2013/06/03 | 1,273 | 1,274 | 1,201 | 1,245 | -30 | -2.4% | 123,000 |
| 2013/05/31 | 1,290 | 1,310 | 1,267 | 1,275 | -8 | -0.6% | 195,000 |
| 2013/05/30 | 1,321 | 1,331 | 1,282 | 1,283 | -62 | -4.6% | 133,000 |
| 2013/05/29 | 1,317 | 1,362 | 1,311 | 1,345 | +28 | +2.1% | 184,000 |
| 2013/05/28 | 1,315 | 1,331 | 1,290 | 1,317 | -4 | -0.3% | 184,000 |
| 2013/05/27 | 1,355 | 1,355 | 1,314 | 1,321 | -23 | -1.7% | 191,000 |
| 2013/05/24 | 1,330 | 1,380 | 1,321 | 1,344 | +13 | +1% | 366,000 |
| 2013/05/23 | 1,409 | 1,434 | 1,331 | 1,331 | -94 | -6.6% | 273,000 |
| 2013/05/22 | 1,451 | 1,453 | 1,424 | 1,425 | -30 | -2.1% | 192,000 |
| 2013/05/21 | 1,451 | 1,466 | 1,447 | 1,455 | +3 | +0.2% | 226,000 |
| 2013/05/20 | 1,478 | 1,479 | 1,445 | 1,452 | +2 | +0.1% | 185,000 |
| 2013/05/17 | 1,400 | 1,479 | 1,376 | 1,450 | +52 | +3.7% | 407,000 |
| 2013/05/16 | 1,373 | 1,400 | 1,363 | 1,398 | +25 | +1.8% | 299,000 |
| 2013/05/15 | 1,373 | 1,390 | 1,360 | 1,373 | ±0 | ±0% | 245,000 |
| 2013/05/14 | 1,350 | 1,379 | 1,340 | 1,373 | +75 | +5.8% | 395,000 |
| 2013/05/13 | 1,319 | 1,319 | 1,282 | 1,298 | -7 | -0.5% | 171,000 |
| 2013/05/10 | 1,308 | 1,324 | 1,298 | 1,305 | -2 | -0.2% | 157,000 |
| 2013/05/09 | 1,336 | 1,344 | 1,307 | 1,307 | -30 | -2.2% | 82,000 |
| 2013/05/08 | 1,362 | 1,366 | 1,330 | 1,337 | -13 | -1% | 161,000 |
| 2013/05/07 | 1,307 | 1,355 | 1,307 | 1,350 | +58 | +4.5% | 175,000 |
| 2013/05/02 | 1,283 | 1,300 | 1,279 | 1,292 | +10 | +0.8% | 88,000 |
| 2013/05/01 | 1,277 | 1,291 | 1,272 | 1,282 | -14 | -1.1% | 118,000 |
| 2013/04/30 | 1,295 | 1,324 | 1,293 | 1,296 | -15 | -1.1% | 122,000 |
| 2013/04/26 | 1,346 | 1,349 | 1,310 | 1,311 | -30 | -2.2% | 252,000 |
| 2013/04/25 | 1,300 | 1,346 | 1,296 | 1,341 | +43 | +3.3% | 216,000 |
| 2013/04/24 | 1,297 | 1,305 | 1,290 | 1,298 | +4 | +0.3% | 89,000 |
| 2013/04/23 | 1,277 | 1,297 | 1,266 | 1,294 | +26 | +2.1% | 156,000 |
| 2013/04/22 | 1,282 | 1,290 | 1,267 | 1,268 | +3 | +0.2% | 89,000 |
| 2013/04/19 | 1,264 | 1,270 | 1,253 | 1,265 | -3 | -0.2% | 55,000 |
| 2013/04/18 | 1,279 | 1,284 | 1,260 | 1,268 | -14 | -1.1% | 77,000 |
| 2013/04/17 | 1,278 | 1,286 | 1,272 | 1,282 | +4 | +0.3% | 70,000 |
| 2013/04/16 | 1,251 | 1,282 | 1,241 | 1,278 | +5 | +0.4% | 166,000 |
| 2013/04/15 | 1,277 | 1,290 | 1,266 | 1,273 | -4 | -0.3% | 72,000 |
| 2013/04/12 | 1,289 | 1,289 | 1,265 | 1,277 | -11 | -0.9% | 100,000 |
| 2013/04/11 | 1,286 | 1,295 | 1,261 | 1,288 | +21 | +1.7% | 222,000 |
| 2013/04/10 | 1,236 | 1,269 | 1,230 | 1,267 | +34 | +2.8% | 182,000 |
| 2013/04/09 | 1,226 | 1,238 | 1,214 | 1,233 | +15 | +1.2% | 146,000 |
| 2013/04/08 | 1,209 | 1,249 | 1,191 | 1,218 | +10 | +0.8% | 178,000 |
| 2013/04/05 | 1,199 | 1,222 | 1,186 | 1,208 | +20 | +1.7% | 158,000 |
| 2013/04/04 | 1,161 | 1,188 | 1,140 | 1,188 | +27 | +2.3% | 147,000 |
| 2013/04/03 | 1,125 | 1,177 | 1,125 | 1,161 | +21 | +1.8% | 127,000 |
| 2013/04/02 | 1,159 | 1,176 | 1,128 | 1,140 | -4 | -0.3% | 161,000 |
| 2013/04/01 | 1,197 | 1,197 | 1,141 | 1,144 | -71 | -5.8% | 173,000 |
2801～
2850
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
